Aromatic polyketides are assembled by a type II (iterative) polyketide synthase (PKS) in bacteria. Understanding the enzymology of such enzymes should provide the information needed for the synthesis of novel polyketides through the genetic engineering of PKSs. Using a previously described cell-free system [B.S. & C.R.H. (1993) Polyketide metabolites are one of the largest groups of natural products, many of which are clinically valuable antibiotics or chemotherapeutic agents, or exhibit other pharmacological activities (1, 2). Despite their apparent structural diversity, they share a common mechanism of biosynthesis. The carbon backbone of a polyketide results from sequential condensation of short fatty acids, such as acetate, propionate, or butyrate, in a manner resembling fatty acid biosynthesis but is catalyzed by polyketide synthases (PKSs). A strong sequence and mechanistic similarity among many of the PKSs has led to two paradigms for explaining polyketide biochemistry: type I PKSs, multifunctional proteins that harbor a distinct active site for every enzyme-catalyzed step, and type II PKSs, multienzyme complexes that carry a single set of iteratively used activities and consist of several largely monofunctional proteins for the synthesis of complex largely reduced polyketides, like macrolide antibiotics, or aromatic polyketides, like tetracyclines (3, 4, 5). Studies of polyketide biosynthesis provide an excellent model for elucidating the structure-function relationship of complex multienzyme systems, and engineered PKSs have considerable potential for synthesizing novel polyketides (6-9).
Polyketide metabolites are one of the largest groups of natural products, many of which are clinically valuable antibiotics or chemotherapeutic agents, or exhibit other pharmacological activities (1, 2) . Despite their apparent structural diversity, they share a common mechanism of biosynthesis. The carbon backbone of a polyketide results from sequential condensation of short fatty acids, such as acetate, propionate, or butyrate, in a manner resembling fatty acid biosynthesis but is catalyzed by polyketide synthases (PKSs). A strong sequence and mechanistic similarity among many of the PKSs has led to two paradigms for explaining polyketide biochemistry: type I PKSs, multifunctional proteins that harbor a distinct active site for every enzyme-catalyzed step, and type II PKSs, multienzyme complexes that carry a single set of iteratively used activities and consist of several largely monofunctional proteins for the synthesis of complex largely reduced polyketides, like macrolide antibiotics, or aromatic polyketides, like tetracyclines (3, 4, 5) . Studies of polyketide biosynthesis provide an excellent model for elucidating the structure-function relationship of complex multienzyme systems, and engineered PKSs have considerable potential for synthesizing novel polyketides (6) (7) (8) (9) .
So far, the examination of type II PKS genes in vivo has revealed limited information about how type II PKSs control product structure, in part because the active sites for the RCOSEnz and CH2(CO2H)COSEnz condensation and oligoketide cyclization reactions are used more than once and, therefore, must recognize different substrates in each bondforming event, as exemplified by the tetracenomycin (Tcm) PKS from Streptomyces glaucescens (see Fig. 1 ) (10) (11) (12) . We have previously described a cell-free system to facilitate the purification and reconstitution of individual components of type II PKSs (11) , using the Tcm PKS as a model. That work showed that the Tcm PKS consists of the TcmJKLMN proteins (10, (12) (13) (14) , although components of a S. glaucescens fatty acid synthase may also be required (11, 15) . We now report the purification of the TcmN polyketide cyclase and its interaction with the other Tcm PKS proteins (i.e., TcmJKLM), which reveals important mechanistic details about how a type II PKS assembles aromatic polyketides.
MATERIALS AND METHODS
Expression oftcmN in Streptomyces lividans and Purification of TcmN. A 0.5-kb fragment containing the ermE* promoter was subcloned from pWHM862 (16) into the EcoRI/SstI sites of pGEM3zf (Promega) to give pWHM79. The tcmN gene was then moved as a 1.8-kb BglII/SphI fragment from pWHM862 into the BamHI/SphI sites of pWHM79 to give pWHM80, from which a 2.3-kb BamHI/EcoRI fragment containing ermE*::tcmN was moved into the similar sites of pWHM862 to yield pWHM74. Transformation of pWHM74 into S. lividans 1326, preparation of cell-free extract from S. lividans 1326 (pWHM74), and SDS/PAGE analysis were performed as described (17) . The cell-free extract was fractionated by addition of solid (NH4)2SO4. The pellet resulting from 31% to 46% saturation was collected, dissolved in a minimum amount of 25 mM Tris HCl buffer (pH 8.0)/1 mM DTT/150 mM NaCl, and resolved on a Sephacryl S-200 HR column (2.6 x 60 cm) eluted with the same buffer. The TcmN-containing fractions after the gel filtration chromatography, assayed as described below, were loaded onto a Mono Q HR 10/10 (Pharmacia) column in 25 mM Tris-HCl buffer (pH 8.0)/1 mM DTT and eluted at a flow rate of 2 ml/min with a linear 80-ml gradient from 0.1 to 0.5 M NaCl in the same buffer. Fractions containing TcmN from the anion exchange chromatography were brought to 1.0 M (NH4)2SO4, applied to an Alkyl Superose HR 5/5 (Pharmacia) column, and eluted at a flow rate of 0.5 ml/min with a linear 15-ml gradient from 1.2 to 0.48 M (NH4)2SO4 in 50 mM sodium phosphate buffer (pH 7.2)/1.0 mM DTT to yield pure TcmN.
Abbreviations: PKS, polyketide synthase; Tcm, tetracenomycin.
The molecular weight of the native TcmN was determined by gel filtration chromatography on a Sepharose 6 HR 10/30 (Pharmacia) column. The column was eluted with a flow rate of 0.5 ml/min in 25 mM Tris HCl buffer (pH 8.0)/150 mM NaCl/1 mM DTT and calibrated with blue dextrin (2 x 106), alcohol dehydrogenase (Mr 150,000), BSA (Mr 66,000), and carbonic anhydrase (Mr 29,000); (Sigma).
Expression of tcmN in Escherichia coli. Amplification of the tcmN gene by PCR was performed as described (17) . The sequences of the primers were as follows (restriction enzyme sites are underlined and modified bases are shown in bold): 5 '-GGAATTCCATGGCTGCTCGTACCGACAACTCC-ATCGTCGTCAACGCGCCGTTC-3' and 3'-ACCTGGTG-CGACCTCACGGCGGGGCAGATCCTAGGTCG-5'. The amplified 1.5-kb tcmN fragment was digested with NcoI and BamHI and cloned into the similar sites of pET14b (Novagen) to yield pWHM78. Transformation of pWHM78 into E. coli BL21(DE3) and preparation of cell-free extract from E. coli BL21(DE3)(pWHM78) were carried out on the pET system according to the manufacturer's instructions (Novagen). TcmN was then purified as above.
Assay for TcmN O-Methyltransferase Activity. To assay the methyl transferase activity of TcmN, a 500-,l solution with 5% dimethyl sulfoxide consisting of 100 ,iM Tcm D3 (18) , 250 ,uM S-adenosylmethionine, and 2.6 ,ug of TcmN in 50 mM Tris HCl buffer (pH 8.0) was incubated at 25°C. After 10 min of preincubation, the assays were initiated by addition of Tcm D3, incubated at 25°C, and terminated by addition of 50 ,ul of 20% trichloroacetic acid. They were then saturated with NaCl and extracted with EtOAc (2 x 500 ,ul), and the EtOAc extracts were concentrated in vacuo. The latter residues were dissolved in CH30H and analyzed by HPLC under the conditions described previously (17) . Tcm D3 and Tcm B3 (19) (12) and purified it on the basis of its O-methyltransferase activity (Fig. 1A) . The tcmN gene was overexpressed in both S. lividans and E. coli to facilitate its purification. In S. lividans, the expression of tcmN was under the control of the strong, constitutive ermE* promoter in pWHM74 (see Materials and Methods). Analysis of a cell-free sample made from S. lividans 1326 transformed with pWHM74 by SDS/PAGE showed a distinctive band that migrated with a Mr of 56,000, indicating that the tcmN gene had been overexpressed in the heterologous host in the soluble form ( Fig. 2A) . Purification of the TcmN protein to homogeneity was accomplished by sequential gel filtration, anion exchange, and hydrophobic interaction chromatography as described in Materials and Methods and summarized in Table 1 . Amino acid analysis of the purified protein yielded a N terminus of AARTDNSIVVNAPEELVXD)VTN, confirming the translational start site assigned previously to tcmN based on genetic analysis (12) . We then used PCR to create a unique NcoI site at the ATG start site and a BamHI site after the TAG stop site to facilitate the construction of pWHM78 for tcmN expression in E. coli as described in Materials and Methods. Codons 2-5 of the tcmN gene were also modified for the optimal expression in E. coli (20) . SDS/PAGE analysis of samples from E. coli BL21(DE3) transformed with pWHM78 showed that the tcmN gene was efficiently expressed and that approximately 90% of the TcmN protein was produced in the soluble form ( Fig. 2B) , from which it was purified to homogeneity by the procedures used for TcmN from S. lividans (Table 1) .
Since the most likely substrate for the TcmN polyketide cyclase would be the PKS-bound linear decaketide (Fig. 1A) , which cannot be prepared chemically because of its inherent reactivity, we purified TcmN by following the Tcm D3 0-methyltransferase activity. In agreement with our earlier prediction (12), the purified TcmN protein catalyzed the specific O-methylation of Tcm D3 to yield Tcm B3 (Fig. 1A) , using S-adenosylmethionine as the methyl donor, and showed optimal activity around pH 8.0. TcmN produced in either S. lividans or E. coli was identical, as evidenced by a similar specific activity of 26.0 or 27.8 nmol min-l mg-1, respectively, in the Tcm D3 O-methyltransferase assay (Table 1) cyclized shunt products, although the existence of the enzymebound linear polyketide (Fig. 1A) has been assumed. We reported earlier that the S. glaucescens WMH1077(pWIHM731) transformant carrying the tcmJKLM genes synthesized decaketide metabolites in vivo (9); its cell-free preparation catalyzed the synthesis of apparent decaketide metabolites from acetyl-and malonyl-CoA in vitro (11) , implying that the TcmJKLM proteins are competent to synthesize the full-length decaketide in the S. glaucescens WMH1077 background. Based on these results, the nascent linear decaketide (Fig. 1A) is likely to be the direct substrate for TcmN, which in the absence of any cyclase could slowly undergo aberrant cyclizations as evidenced by the observation of a mixture of cyclized compounds among which only Tcm F2 (18) and SEK15 (21) have been identified (9) . To test this hypothesis, we supplemented the cell-free preparation of S. glaucescens WMH1077 (pWHM731) with purified TcmN with the anticipation that TcmN would subvert all aberrant reactions by regiospecifically cyclizing the linear decaketide into Tcm F2. As shown in Fig.  3D , Tcm F2 was by far the major product synthesized, and all other pattems of cyclization, including the one leading to the formation of SEK15 (Fig. 3C) sumably established. Substrates and products free from the PKS complex were removed by passing the incubation mixture through a Sephadex G-25 column (Pharmacia), and the resulting enzyme solution was saturated with NaH2PO4 and denatured by extraction with EtOAc to isolate any noncovalently enzyme-bound products. Surprisingly, Tcm F2 was the only enzyme-bound product observed (Fig. 3E) despite the fact that a complex mixture consisting of Tcm F2, SEK15, and other unidentified products was synthesized in the assay reaction and recovered by solvent extraction (Fig. 3C) . Since SEK15 and the products other than Tcm F2 did not appear with the eluted protein (Fig. 3 C vs. E) , Tcm F2 appears to adhere to the Tcm PKS by a tight noncovalent interaction. Covalent attachment by a thioester bond to the 4'-phosphopantetheinyl-SH group of the TcmM acyl carrier protein (13) is not excluded by the data but is less likely because this bond should have been stable to the isolation conditions (22) . Regardless, the normal product Tcm F2 clearly is bound much tighter than the aberrant products. This result could mean that the PKS complex has a specific binding pocket fitting only the normal product, Tcm F2, and forcing the abnormally cyclized ones like SEK15 off the enzyme complex. This binding pocket might also fold the decaketide intermediate into the shape leading to the linearly fused ring system of Tcm F2.
When this experiment was repeated under the identical conditions with the addition of purified TcmN, Tcm F2 was the sole enzyme-bound product again, but the amount of Tcm F2 trapped was more than 10-fold higher than that from TcmJKLM alone (Fig. 3 Fvs. E). From these results, we conclude that the linear decaketide intermediate, the actual substrate for the TcmN cyclase, is enzyme-bound, most likely as an acylthioester to TcmM. In the absence of a cyclase, it cannot efficiently undergo regiospecific cyclization to Tcm F2 and, as a result, falls off the enzyme complex either before or during the aberrant cyclization, as evident from the fact that no other cyclized product apart from Tcm F2 appeared to be enzymebound. ,ul). (E and F) The assay solutions were incubated at 30°C for 20 min followed by a passage through a Sephadex G-25 column; the resulting solutions were worked up as above. (G and H) The assay solutions were incubated at 30°C for 20 min and passed through a Sephadex G-25 column, and 100 ,ug of TcmN was added, followed by incubation at 30°C for an additional 20 min. The assay solution was then added to a Centricon 10 device to separate the proteins from the solution; the retained proteins, dissolved in 500 ,ul of H20, and the solution were Separation of the solution from the proteins was accomplished by passage through a Centricon 10 device (Amicon). Analysis of both the filtrate and protein portions showed that no Tcm F2 was released into the assay solution (Fig. 3G) and that all the Tcm F2 was still bound to the enzyme (Fig. 3H) (28) . We also examined the idea that the interaction of TcmN with TcmJKLM is essential for the Tcm PKS to efficiently assemble the decaketide from acetyl-and malonyl-CoA. Based on in vivo results, Khosla, Hopwood, and coworkers (8) and we (9) have concluded that the "minimal PKS" (i.e., the TcmKLM proteins or their closely related proteins in other type II PKSs) is responsible for the assembly of a given length linear polyketide. Furthermore, we believe that the regiospecificity of the subsequent cyclizations is determined only by the polyketide cyclases. However, these data neither reveal how the linear polyketide is channeled from the minimal PKS to the cyclase nor prove that the synthase and cyclase activities function autonomously. The data presented above confirm the polyketide cyclase-directed regiospecific cyclization of an enzyme-bound polyketide yet raise the question of whether the cyclase also influences how the minimal PKS assembles the linear decaketide, a question that can be addressed only with purified proteins. It is clear by comparing Fig. 3 C with D and E with F that addition of TcmN to the TcmJKLM proteins not only alters the product from a mixture (Fig. 3C ) to largely Tcm F2 (Fig. 3D) , as expected from the cyclase activity, but also increases the total yield of the polyketide synthesized from acetyl-and malonyl-CoA 5-to 10-fold (the variation observed between experiments). Since TcmN does not appear to be able to speed up the synthesis by facilitating the release of Tcm F2 from the PKS enzyme, the increased production of Tcm F2 must reflect increased ability to assemble the linear decaketide from acetyl-and malonyl-CoA. (This prediction cannot be verified by measuring enzyme turnover rates because the amount of Tcm PKS in our cell-free preparation is not known nor easily determined.) Therefore, we propose that TcmN is an integral part of the Tcm PKS complex, although it does not directly catalyze assembly of the linear decaketide. Although the TcmJKLM proteins can form a complex to assemble the decaketide inefficiently and form some Tcm F2 spontaneously, I I it is the interactions between the TcmN and TcmJKLM proteins that constitute an optimal Tcm PKS complex. This model is in agreement with our finding that both the linear decaketide and Tcm F2 appear to be enzyme-bound, implying the close proximity between TcmN and the minimal Tcm PKS proteins, and is consistent with the in vivo studies (9, 29) in which addition of cyclases to a minimal PKS construct caused an increase in the production of metabolites.
Sequence analysis of the tcmN gene (12) showed that only the N-terminal portion of the deduced amino acid sequence is homologous to other putative polyketide cyclase genes or their closely related aromatases (30) , such as the ActVII protein from S. coelicolor (31) . The latter type of proteins exhibits an internal "duplication" motif in which the sequences of the Nand C-terminal halves of the protein are similar (32) . One hypothesis for this sequence duplication is that the two halves could fold internally to form the active conformation. For TcmN to achieve a similar conformation, two molecules of TcmN would be required, each one providing half of the homodimer. This prediction is supported by the size of TcmN determined by gel filtration chromatography (Materials and Methods), where it eluted with an apparent Mr of 103,000, indicating that TcmN is indeed a homodimer in solution.
The results presented here and previously (11) reinforce the idea that the optimal Tcm PKS is a complex consisting of the TcmJKLMN proteins. It is the integrity of this complex that maximizes the efficiency for the synthesis of aromatic polyketides from acetyl-and malonyl-CoA. The nascent linear polyketide intermediate, whose length is determined by the TcmKL proteins (9, 33), appears to be enzyme-bound and is cyclized regiospecifically by the TcmN component of the very same complex. Disrupting or weakening the interactions among these proteins could either completely destroy the PKS activity, as noticed early in the constructions of an actinorhodin/tetracenomycin hybrid PKS (9), using genes shown in Fig. 1B , or lead to an inefficient PKS complex such as the TcmJKLM proteins reported here. Early departure of the decaketide intermediate from the PKS complex results in aberrant cyclization (8, 9) , and this could lead to an erroneous conclusion about the enzymatic properties of a given cyclase or aromatase in hybrid PKSs. These findings must be now taken into consideration in future attempts to produce novel polyketides through the rational engineering of type II PKSs.
